Peter Cicala

Peter Cicala

Director/Board Member at ERNEXA THERAPEUTICS INC.

Net worth: - $ as of 2026-06-29

64 year
Health Technology
Consumer Services

Profile

Peter Cicala is the founder of Boundless Bio, Inc. (2019).
Mr. Cicala is an Independent Director at Ernexa Therapeutics, Inc. since 2024.
Formerly, Chief Intellectual Property Counsel at Intercept Pharmaceuticals, Inc. (2020-2021) and Chief Patent Counsel at Celgene Corp.
(2014-2019).
Education includes an undergraduate degree from Fairleigh Dickinson University and a graduate degree from Seton Hall University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-06 0 ( -.--% ) - $ 2026-06-29

Peter Cicala active positions

CompaniesPositionStart
ERNEXA THERAPEUTICS INC. Director/Board Member 2024-02-11

Former positions of Peter Cicala

CompaniesPositionEnd
INTERCEPT PHARMACEUTICALS, INC. Corporate Officer/Principal 2021-02-28
CELGENE Corporate Officer/Principal 2019-10-31
BOUNDLESS BIO, INC. Founder -
See the detail of Peter Cicala's experience

Training of Peter Cicala

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology